Prescription drug · ANDA
Quinapril (quinapril hydrochloride) NDC 63187-874
Quinapril hydrochloride 10 mg/1 · Tablet, Film coated · Oral · Proficient Rx LP
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 63187-874-30 | 63187087430 | 30 TABLET, FILM COATED in 1 BOTTLE (63187-874-30)Marketed from Aug 1, 2017 | |
| 63187-874-60 | 63187087460 | 60 TABLET, FILM COATED in 1 BOTTLE (63187-874-60)Marketed from Aug 1, 2017 | |
| 63187-874-90 | 63187087490 | 90 TABLET, FILM COATED in 1 BOTTLE (63187-874-90)Marketed from Aug 1, 2017 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Quinapril
- Generic name (nonproprietary)
- quinapril hydrochloride
- Active ingredients
- Quinapril hydrochloride — 10 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Proficient Rx LP
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 202725
- Marketing start
- Listing expires
- Other FDA classes
- Angiotensin-converting Enzyme Inhibitors (Mechanism)
- Identifiers
- Product ID 63187-874_47f95e90-75fb-4294-b861-9a2349a48e91SPL ID 47f95e90-75fb-4294-b861-9a2349a48e91SPL set ID 42e4f9dd-6032-4257-bd0f-8e9b71027f03RxCUI 312748UNII 33067B3N2M
- Pharmacologic class
- Angiotensin Converting Enzyme Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N463187087430followed by a unit qualifier and the quantityPackage 63187-0874-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Hypertension Quinapril tablets, USP are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with quinapril tablets, USP. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithr…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 202725
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Quinaprilquinapril hydrochloride | Quinapril hydrochloride 10 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 63629-7934 |
| Quinaprilquinapril hydrochloride | Quinapril hydrochloride 40 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | 65862-620 |
| Quinaprilquinapril hydrochloride | Quinapril hydrochloride 5 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | 65862-617 |
| Quinaprilquinapril hydrochloride | Quinapril hydrochloride 10 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | 65862-618 |
| Quinaprilquinapril hydrochloride | Quinapril hydrochloride 20 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | 65862-619 |